University of Arizona’s College of Medicine in Phoenix had a double digit increase in the number of applications compared to last year and it could be influenced by the nation’s top infectious disease expert.

As the vaccines roll out, so do questions and concerns. Dr. Elizabeth Connick, chief of the Division of Infectious Diseases at the UArizona College of Medicine – Tucson, called the vaccine a home run. "These are some of the most important accomplishments in medicine in the last 25 years." Overall, Dr. Connick said, it’s the same vaccine but there are a few differences. "Preliminarily, it does seem like the Moderna causes more side effects, more fatigue and particularly after the second dose. But it could be because you're getting a great immune response."

Dr. Amanda Sokan was recognized for her work in translational medicine that focuses on aging research, curriculum development and public health policy.

Antibody tests, groundbreaking research and community outreach are a few of the ways the University of Arizona Health Sciences met the test of a pandemic.

Antibody tests, groundbreaking research and community outreach are a few of the ways the University of Arizona Health Sciences met the test of a pandemic.

A UArizona Health Sciences public health student and a microbiology student in Canada won a science competition with an Instagram account to refute bad science.

Dr. Sam Keim, a professor of emergency medicine at the University of Arizona College of Medicine - Tucson, is interviewed about his experiences as a clinical trial participant in Moderna's COVID-19 vaccine

A team at the University of Arizona Health Sciences found that SARS-CoV-2 antibodies provide lasting immunity. This finding suggested that those who had survived an infection and those who received a vaccine for COVID-19 would be immune from reinfection for several months.

Sandra Kurtin, PhD, ANP-C, AOCN, of the University of Arizona Cancer Center, discusses the challenges for advanced practitioners treating patients with hematologic malignancies who are at high risk for COVID-19 infection.